Gitnux/Report 2026

Orthopedics Industry Statistics

The orthopedics market is forecast to reach $67.1B in 2032—how $10.4B in spinal fusion products and other procedure-driven categories shape growth.
294Statistics
81Sources
12Sections
1Visuals
48mRead
November 10, 2026Updated
Orthopedics Industry Statistics
Henrik DahlWritten by Henrik Dahl·Edited by Marie Larsen·Fact-checked by Abigail Foster
Published ·Updated
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 39 days

01 Industry overview

The orthopedics industry at a glance

The global orthopedics market reached $64.9 billion in 2025, with joint replacement, trauma and enabling technologies supporting continued mid-single-digit growth despite normalization after post-pandemic demand.

$64.9B[14]
Global sales, 2025
4.3%[69]
Forecast CAGR, 2026–2035
14,100[70]
U.S. orthopedic surgeons, 2025
45%[71]
North America share, 2023
Market size
ORTHOWORLD reported worldwide orthopedic sales of $64.954 billion in 2025, up 4.9% from $61.939 billion in 2024. A separate market estimate put orthopedic devices at $60.6 billion in 2025, reflecting differences in scope and methodology.[14][69]
Forecast & CAGR
Global Market Insights forecasts the orthopedic devices market to increase from $63.0 billion in 2026 to $92.2 billion in 2035, representing a 4.3% CAGR. Grand View Research also projected a 4.3% CAGR for 2024–2030 in an earlier market definition.[69][71]
Market share & regions
North America accounted for 45% of orthopedic-device revenue in 2023 according to Grand View Research, with the United States representing 93.3% of North American revenue. Global Market Insights identifies North America as the largest regional market and Asia-Pacific as the fastest-growing region in its 2026–2035 outlook.[71][69]
Segmentation
In 2025, joint replacement generated $23.863 billion, followed by spine at $11.138 billion, trauma at $9.596 billion and sports medicine at $7.577 billion. Within joint replacement, knees generated $11.201 billion, hips $9.161 billion and extremities $3.501 billion.[14]
Key players & concentration
ORTHOWORLD reported that eight companies with more than $1 billion in annual orthopedic sales controlled about two-thirds of the worldwide market in 2025 and generated more than $43.3 billion in combined orthopedic revenue. Global Market Insights identified DePuy Synthes as the 2025 market leader with more than 14.5% share in its market definition.[14][69]
Trends, drivers & challenges
Demand is supported by aging populations, orthopedic disease prevalence, joint-replacement volumes and technology adoption, including robotics and biologics. ORTHOWORLD reported 2025 growth of 9.4% for enabling technology, 8.3% for extremities and 5.8% for both trauma and sports medicine, while noting normalization from unusually strong recent growth and softness in foot and ankle.[14][69]
Consumer behavior & competition
The American Joint Replacement Registry reported more than 4 million captured hip and knee arthroplasty procedures by March 2024 and analyzed 3.715 million validated procedures performed from 2012 through 2023. Its 2024 report also covered 1,447 institutions, including 312 ambulatory surgery centers, indicating growing data capture and competition across hospital and ASC care settings.[72][73]
M&A
Zimmer Biomet completed its $1.24 billion acquisition of Paragon 28 in April 2025, adding a focused foot-and-ankle platform. It also completed the acquisition of Monogram Technologies in October 2025 to expand orthopedic robotics and pursue semi-autonomous and autonomous surgical capabilities; Johnson & Johnson announced in October 2025 its intent to separate its orthopedics business as DePuy Synthes.[16][45]
Regulation
In the United States, orthopedic devices are regulated through pathways including 510(k) clearance for substantial equivalence and PMA for Class III devices. FDA records show a 2026 510(k) clearance for Stryker’s Triathlon and Scorpio knee systems, a 2026 De Novo classification for Smith+Nephew’s TESSA orthopedic navigation system, and updated FDA guidance and classification activity for orthopedic devices in November 2026.[11][74]
Latest news
The latest FDA device-regulatory update identified in the search was published on November 4, 2026 and included Federal Register classification of a wearable vibration device for orthopedic use. The FDA’s November 2026 CDRH update also highlighted continuing work on quality-management-system and medical-device-cybersecurity requirements.[74]

02 Ranking

Top 10 Companies in the Orthopedics Industry

The leading companies in the orthopedics industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 9, 2026 · Next review December 9, 2026

Verdict

Stryker and Johnson & Johnson are tied at the top of Gitnux's 2026 orthopedics ranking with an Overall score of 9.1 each.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in orthopedic implants

    Stryker

    US

    Ranked #1 · 9.1 · Orthopedic implants

    Why we picked it: It spans joint replacement, trauma, spine and sports medicine, with $11.4 billion orthopedic sales in 2025.

    See in ranking ↓Visit stryker.com ↗

  2. Leader in orthopedic surgical systems

    Johnson & Johnson

    US

    Ranked #2 · 9.1 · Orthopedic surgical systems

    Why we picked it: Its DePuy Synthes orthopedic implants and surgical systems produced $9.3 billion in Orthopaedics sales in 2025.

    See in ranking ↓Visit jnj.com ↗

  3. Leader in orthopedic navigation

    Smith+Nephew

    GB

    Ranked #3 · 8.9 · Orthopedic navigation

    Why we picked it: Its orthopedic implants and navigation products reported $4.15 billion of orthopedic sales in 2025.

    See in ranking ↓Visit smith-nephew.com ↗

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the orthopedics industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Stryker

Orthopedic implants · US

9.1
2

Johnson & Johnson

Orthopedic surgical systems · US

9.1
3

Smith+Nephew

Orthopedic navigation · GB

8.9
4

Atec

Orthopedic enabling technologies · US

8.8
5

Arthrex

Sports medicine & orthobiologics · US

8.8
6

Medtronic

Spinal implants, biologics and enabling technology · IE

8.7
7

Medacta

Hip, knee, spine and extremity implants · CH

8.6
8

Össur

Orthopedic bracing, supports and prosthetic limbs · IS

8.6
9

Enovis

Reconstruction, extremities and recovery products · US

8.1
10

Orthofix

Spine, limb reconstruction and bone growth therapies · US

7.9

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 9, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Henrik Dahl. (2026, February 13). Top 10 companies in the orthopedics industry. In Orthopedics Industry Statistics. Gitnux. https://gitnux.org/orthopedics-industry-statistics/#top-companies

report visual · Comparison

Orthopedic sales by company, FY2024

Stryker leads with $10.9B.

Stryker$10.9B
J&J MedTech$9.2B
Zimmer Biomet$7.7B
Smith+Nephew$3.9B
Medtronic$3.4B
Arthrex$3.1B
source-verifiedbonezonepub.com

04 Statistics

Technology & Innovation

Technology adoption is quantified by robotics penetration (6.7% of U.S. hip, knee and spine surgeries in 2023) and AI expectations from a 2023 aspiring-surgeon survey.

AI in the orthopedics industry

  • 59.3% of surveyed aspiring orthopaedic surgeons identified AI-powered monitoring for early complication detection as a likely application, in 2023.[1]
  • 89.3% of aspiring orthopaedic surgeons believed AI would comprehensively assist with core medical tasks such as performing surgery, in a multinational survey conducted in 2023.[2]
  • 62% of aspiring orthopaedic surgeons believed AI would comprehensively assist with administrative tasks such as documentation, in 2023.[2]
  • 82% of aspiring orthopaedic surgeons believed AI would comprehensively assist with other medical tasks such as radiological assessment or anamnesis, in 2023.[2]
  • 81.3% of surveyed aspiring orthopaedic surgeons identified AI-powered image analysis for diagnosis and fracture classification as a likely application, in 2023.[1]
  • 85.3% of surveyed aspiring orthopaedic surgeons identified AI-powered implant planning as a likely tool they would use in practice, in 2023.[1]

Automation in the orthopedics industry

  • Approximately 25% of operating rooms had access to an orthopaedic robot in 2025, according to an orthopaedic market analysis.[3]
  • 6.7% of U.S. hip, knee and spine orthopaedic surgeries used robotic assistance in 2023, up from 3.0% in 2017.[2]
  • 4.4% of U.S. hip arthroplasties used robotic assistance in 2023, compared with 3.2% in 2017.[2]
  • 1.3% of U.S. spine arthrodesis surgeries used robotic assistance in 2023, up from 0.2% in 2017.[2]
  • 13.8% of U.S. knee arthroplasties used robotic assistance in 2023, up from 5.7% in 2017.[2]
  • 57,920 of 1,072,714 U.S. hip, knee and spine surgeries in the study used robotic assistance during 2017–2023, representing 5.1%.[2]

Digital Transformation in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare practitioners, 60% believed their organizations’ digital experiences met or exceeded customer needs in 2025.[4]
  • About 70% of surveyed healthcare executives said investing in technology platforms for digital tools and services would be important or very important in 2025.[5]
  • Across U.S. non-federal acute care hospitals, 71% used predictive AI integrated into electronic health records in 2024.[6]
  • About 90% of surveyed global healthcare C-suite executives expected digital technology use to accelerate in 2025, including 50% anticipating a significant impact.[5]
  • Among healthcare respondents to KPMG’s global technology survey, 49% were adopting DevSecOps approaches to adapt digital-transformation strategies.[7]

Technology Adoption in the healthcare services sector (sector benchmark)

  • Across U.S. non-federal acute care hospitals, 96% enabled patients to download health information electronically in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 84% enabled patients to transmit health information to a third party electronically in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 92% enabled patients to securely message providers in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 99% enabled patients to view health information electronically in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 70% enabled patient access through applications using HL7 FHIR specifications in 2024.[6]
  • Across U.S. non-federal acute care hospitals, 81% enabled patient access through applications using application-programming-interface specifications in 2024.[6]

Cloud Computing in the healthcare services sector (sector benchmark)

  • Across surveyed healthcare organizations globally, 8% reported minimal cloud adoption without formal strategy or governance at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 15% reported that cloud adoption was fully integrated into business strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 27% reported that cloud operations were well managed and integrated into overall IT strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 18% had started adopting cloud services but lacked a comprehensive cloud strategy at the end of 2025.[8]
  • Across surveyed healthcare organizations globally, 31% had a formal cloud strategy and governance framework that was not yet integrated into IT strategy at the end of 2025.[8]

Big Data in the healthcare services sector (sector benchmark)

  • Across Brazilian healthcare facilities conducting Big Data analytics, 48% used social-media data in 2024.[9]
  • Across Brazilian healthcare facilities conducting Big Data analytics, 38% used geolocation data from mobile phones, wireless connections, or GPS in 2024.[9]

05 Statistics

Data & Analytics

Implant-surveillance scale and claims-based revision metrics are explicit, including 0.5% two-year septic hip-revision rates in New York State and California.

Business intelligence in the orthopedics industry

  • 170,520 total hip-replacement procedures were included in Kaiser Permanente’s implant-surveillance program through 2022, United States.[10]
  • 303,844 total knee-replacement procedures were included in Kaiser Permanente’s implant-surveillance program through 2022, United States.[10]
  • 92,352 spine procedures were included in Kaiser Permanente’s implant-surveillance program through 2022, United States.[10]
  • 135,165 primary total hip arthroplasties were tracked by Kaiser Permanente’s registry through 2021, United States.[10]
  • 71,087 hip-fracture procedures were included in Kaiser Permanente’s implant-surveillance program through 2022, United States.[10]
  • 244,952 primary total knee arthroplasties were tracked by Kaiser Permanente’s registry through 2021, United States.[10]

Data analytics in the orthopedics industry

  • 0.5% was the two-year septic hip-revision rate in New York State in the claims-data analysis.[2]
  • 0.5% was the two-year septic hip-revision rate in California in the claims-data analysis.[2]
  • 37 knee revisions were attributed to infection among the cases described in the 2026 FDA adverse-event report using Australian registry data.[11]
  • 1,001 knees underwent primary total knee arthroplasty with a Smith+Nephew Legion revision tibial baseplate between May 16, 2006 and November 17, 2025, according to Australian registry data cited in an FDA report.[11]
  • 10 knee revisions were attributed to loosening among the cases described in the 2026 FDA adverse-event report using Australian registry data.[11]
  • 132,826 total hip-replacement patients were included in a New York and California claims-data analysis of two-year revision outcomes.[2]

Data Quality in the healthcare services sector (sector benchmark)

  • 75% of U.S. healthcare organizations represented in the survey predominantly used clinical registry data for quality and process improvement in 2024.[12]
  • 8% of U.S. healthcare organizations rated their provider data as excellent in 2022.[13]
  • 40% of U.S. healthcare clinical data abstractors reported that incomplete data hampers clinical registry efforts in 2024.[12]
  • 40% of U.S. healthcare clinical data abstractors reported that manual data entry hampers clinical registry efforts in 2024.[12]
  • 50% of U.S. healthcare clinical data abstractors reported that data inaccuracies hamper clinical registry efforts in 2024.[12]

Data Governance in the healthcare services sector (sector benchmark)

  • 72% of healthcare organizations operated governance using approved policy and standards frameworks in 2025.[13]
  • 38% of healthcare organizations had formal data and information quality-management statements in 2025.[13]
  • 77% of healthcare organizations reported that their governance functions met at least quarterly in 2025.[13]
  • 10% of healthcare organizations managed data governance exclusively within IT in 2025.[13]
  • 66% of healthcare organizations reported multidisciplinary representation in governance, including patient or consumer representatives, in 2025.[13]
  • 39% of healthcare organizations reported having a formally chartered data-governance function in 2025.[13]

KPIs in the orthopedics industry

  • 47% of primary total knee arthroplasties used highly cross-linked polyethylene in 2024, United States.[2]
  • 12% of primary total knee arthroplasties used conventional polyethylene in 2024, down from 15% in 2023, United States.[2]
  • 34% of primary total knee arthroplasties used posterior-stabilized inserts in 2024, down from 40% in 2023, United States.[2]
  • 43% of primary total knee arthroplasties used medial-congruent inserts in 2024, up from 33% in 2023, United States.[2]
  • 41% of primary total knee arthroplasties used antioxidant highly cross-linked polyethylene in 2024, United States.[2]
  • 6.6% of primary total knee arthroplasties used cruciate-retaining liners in 2024, compared with 35.6% in 2012, United States.[2]

06 Statistics

Strategy & Growth

Growth is broken out by procedure categories and by enabling activities; enabling technology showed 9.4% 2025 growth in ORTHOWORLD reporting.

Growth in the orthopedics industry

  • The eight largest orthopedic companies generated $43.54 billion in sales in 2025, up 5.6% from 2024.[14]
  • The global orthopedic market grew 4.9% to $64.95 billion in 2025.[14]
  • Orthopedic sales outside the United States grew 4.7% to $20.33 billion in 2024.[15]
  • Enovis’s orthopedic sales increased 10.0% to $1.11 billion in 2025.[14]
  • Globus Medical’s orthopedic sales increased 16.7% to $2.94 billion in 2025.[14]
  • Zimmer Biomet’s total net sales increased 3.8% to $7.68 billion in 2024.[16]

Differentiation in the orthopedics industry

  • Stryker’s spinal implants represented 8% of its orthopaedics net sales in 2024, with $707 million in sales.[17]
  • Zimmer Biomet acquired OrthoGrid in 2024 to add an artificial-intelligence surgical-guidance platform for total hip replacement and two additional orthopedic applications.[17]
  • Stryker’s trauma and extremities products represented 39% of its orthopaedics net sales in 2024.[17]
  • Some orthopedic companies with robotic offerings gained 1% to 2% of segment market share over the five years through 2024.[3]
  • Stryker’s 2024 orthopedic sales included $2.45 billion from knees, $1.70 billion from hips and $3.51 billion from trauma and extremities.[17]
  • The top six orthopedic companies with more than $1 billion in sales each had at least one robotic system in their technology ecosystem in 2025.[14]

Mergers and acquisitions in the orthopedics industry

  • Henry Schein acquired a 60% voting interest in TriMed for $315 million on April 1, 2024.[17]
  • The eight largest orthopedic companies accounted for approximately two-thirds of worldwide orthopedic sales in 2025.[14]
  • Enovis acquired LimaCorporate in January 2024 at an enterprise value of €800 million.[17]
  • Zimmer Biomet’s 2024 acquisitions involved initial consideration of $294.8 million and potential additional consideration of up to $111.6 million.[17]
  • The LimaCorporate acquisition contributed $322.5 million of net sales to Enovis in 2024.[17]
  • Zimmer Biomet acquired OrthoGrid Systems on October 11, 2024, adding AI-driven guidance for total hip replacement.[17]

Strategic partnerships in the orthopedics industry

  • Alkem MedTech and Exactech announced a 2024 agreement covering manufacturing and marketing of knee and hip replacement implants in India.[18]
  • The OrthoForum Value Network was described as the largest clinically integrated network of orthopedic and musculoskeletal providers in the United States in 2024.[19]
  • Zimmer Biomet announced a strategic partnership with CBRE in 2024 to develop and outfit orthopedic ambulatory surgery centers in the United States.[16]
  • The Alkem MedTech–Exactech agreement represented Alkem MedTech’s first entry into implantable medical devices in 2024.[18]
  • Tendo and the OrthoForum Value Network announced a 2024 partnership intended to provide employer access to a nationwide orthopedic and musculoskeletal provider network.[19]
  • THINK Surgical intended to file for U.S. FDA 510(k) clearance for the jointly developed Freedom Knee solution in 2024.[20]

07 Statistics

People & Workforce

Workforce planning uses quantified projections and retention initiatives, including 4% projected employment growth for U.S. orthopedic surgeons (except pediatric) from 2025 to 2035.

Hiring in the orthopedics industry

  • 4% employment growth is projected for U.S. orthopedic surgeons, except pediatric, from 2025 to 2035.[21]
  • Orthopaedic surgeon demand in the United States is projected to increase by 4,720 full-time equivalents, or 13%, between 2021 and 2036 under the reduced-barriers scenario.[22]
  • 400 annual job openings for orthopedic surgeons, except pediatric, are projected in the United States for 2025–2035.[21]
  • 16,100 orthopedic surgeons, except pediatric, are projected to be employed in the United States in 2035.[21]
  • 15,500 orthopedic surgeons, except pediatric, were employed in the United States in 2025.[21]

Employee retention in the orthopedics industry

  • 83.4% was the FY25 retention-rate goal for registered nurses in an orthopedic trauma unit quality-improvement initiative.[2]
  • 67.5% was the FY25 retention-rate goal for unlicensed assistive personnel in an orthopedic trauma unit quality-improvement initiative.[2]

Remote Work in the healthcare services sector (sector benchmark)

  • Across U.S. medical groups, 52% reported that 1%–25% of their workforce worked remotely at least 50% of the time.[23]
  • Across U.S. medical groups, 18% of leaders expected their organization’s share of remote or hybrid jobs to decrease during 2024.[23]
  • Across U.S. health care and social assistance, 18% of full-time employees worked fully from home during December 2024–March 2025.[24]
  • Across U.S. medical groups, 22% of leaders expected their organization’s share of remote or hybrid jobs to increase during 2024.[23]

Hybrid Work in the healthcare services sector (sector benchmark)

  • About 6% of U.S. healthcare jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[23]
  • Across U.S. healthcare practitioners and technical roles, 16% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[23]
  • About 12% of nonclinical healthcare administrative and customer-support jobs were hybrid in a 2024 Robert Half survey cited by the Medical Group Management Association.[23]
  • Across U.S. healthcare support roles, 14% had part-time remote availability, equivalent to hybrid availability, in the 2022 McKinsey American Opportunity Survey.[23]
  • Across U.S. health care and social assistance, 24% of full-time employees were in hybrid arrangements during December 2024–March 2025.[24]

Upskilling in the orthopedics industry

  • 14.5% of surveyed orthopedic doctors identified clear professional guidelines as a measure that would facilitate AI adoption.[2]
  • 19.9% of surveyed orthopedic doctors identified dedicated AI courses and training programs as a measure that would facilitate AI adoption.[2]
  • 21.7% of surveyed orthopedic doctors identified strong scientific evidence on AI effectiveness and safety as a measure that would facilitate adoption.[2]

Employee Engagement in the healthcare services sector (sector benchmark)

  • Across NHS staff, the national staff-engagement theme score was 6.64 in the second quarter of 2024/25.[25]
  • U.S. registered nurses with low teamwork scores were 1.53 times more likely to leave their healthcare organization in 2024.[26]
  • Among U.S. healthcare advanced practice providers, 52% felt heard in 2024.[26]
  • Across U.S. healthcare workers, 78% believed their organization cared about their safety in 2024.[26]
  • Across U.S. healthcare organizations, employee turnover fell from 20% to 18% in 2024.[26]

DEI in the orthopedics industry

  • 84.7% of respondents to the 2018 AAOS census identified as Caucasian, while 6.7% identified as Asian, 2.2% as Hispanic or Latino and 1.9% as African American.[2]
  • 3.97% of U.S. arthroplasty orthopaedic diplomates were female in 2023.[2]
  • 7.6% of respondents to the 2018 AAOS census identified as female.[2]
  • 14.0% of orthopaedic surgeons attaining board certification were female in the 2019–2023 U.S. cohort, compared with 3.3% in 1989–1993.[2]
  • 16.7% of U.S. hand orthopaedic diplomates were female in 2023.[2]

Change Management in the healthcare services sector (sector benchmark)

  • Among Canadian healthcare transformation studies, 40% reported successful transformation and 60% reported either success or partial success.[27]

08 Statistics

Customer & Sales

Patient experience reporting is expressed through recommendation likelihood, with 75.5% of orthopedic patients likely to recommend their hospital or provider in 2024.

Customer experience in the orthopedics industry

  • 75.5% of orthopedic patients were likely to recommend their hospital or provider in the 2024 Press Ganey analysis of 59,884 orthopedic encounters in the United States.[7]
  • 72% was the patient-experience percentile rank for hospitals in the 50th–74th engagement quartile in the 2024 Press Ganey analysis.[7]
  • 57% was the patient-experience percentile rank for hospitals in the 25th–49th engagement quartile in the 2024 Press Ganey analysis.[7]
  • 32% was the patient-experience percentile rank for hospitals in the lowest engagement quartile in the 2024 Press Ganey analysis.[7]
  • 80% was the patient-experience percentile rank for hospitals in the highest engagement quartile across the 2024 Press Ganey analysis.[7]

Customer retention in the orthopedics industry

  • 14 provider and practice attributes were evaluated for their relationship with patients staying with and recommending an orthopedic surgeon in the 2023 study.[28]
  • 190 patients participated in a 2023 study of factors influencing continued loyalty to an orthopedic surgeon at an academic orthopedic clinic.[28]

Customer acquisition in the orthopedics industry

  • 279 customer leads were generated on Yelp for Integrated Orthopedics, representing an estimated $200,880 in revenue during the case-study year.[29]
  • 41,507 new users reached the University Orthopaedic Associates website through paid search advertising in the reported campaign period.[30]
  • 3 to 6 locations was the expansion reported for University Orthopaedic Associates after its Google Ads program began in 2014.[30]
  • 538 new patients were acquired directly through a digital-marketing program during one year by Integrated Orthopedics in Phoenix, Arizona.[29]
  • 10 to 24 physicians was the expansion reported for University Orthopaedic Associates after its Google Ads program began in 2014.[30]

Customer loyalty in the orthopedics industry

  • 57.2% of 855 consumers with prior orthopedic surgery followed a doctor’s referral or recommendation when choosing their surgeon in 2018.[31]
  • 1.3 times higher likelihood of recommendation was associated with hospitals demonstrating the strongest teamwork in the 2024 Press Ganey analysis.[7]
  • 35% of 855 surveyed consumers with prior orthopedic surgery said they had actively participated in choosing their surgeon in a 2018 orthopedic-care loyalty survey.[31]
  • 18.7% of 855 consumers with prior orthopedic surgery chose their surgeon independently in the 2018 survey.[31]
  • 75.5% of orthopedic patients were likely to recommend their provider in the 2024 Press Ganey patient-experience analysis.[7]

Lead generation in the orthopedics industry

  • Less than 0.5% of new orthopedic patient leads came from social media, offline channels and email campaigns combined in the 2024 Orthopedics Marketing Benchmark Report.[32]
  • 200 calls per month were generated through search for Integrated Orthopedics during the reported case-study year.[29]
  • 63.1% was the reported conversion rate for paid-search leads in the 2024 Orthopedics Marketing Benchmark Report.[32]
  • 90.2% was the reported share of orthopedic lead volume attributed to paid search in the 2024 Orthopedics Marketing Benchmark Report.[32]
  • 279 Yelp leads were generated for Integrated Orthopedics during one year of digital marketing in Phoenix, Arizona.[29]

09 Statistics

Marketing & Brand

Marketing performance metrics include conversion and ROI figures, including 63.1% conversion rate for paid-search leads in the 2024 Orthopedics Marketing Benchmark Report.

Marketing in the orthopedics industry

  • 43,000-plus impressions were delivered by Salinas Valley Health’s sports-medicine and orthopedics campaign during its initial three-month period.[33]
  • 797 patients were correlated directly to Salinas Valley Health’s sports-medicine and orthopedics campaign after three months of encounter data.[33]
  • $1.2 million in contribution margin was attributed to a three-month sports-medicine and orthopedics campaign at Salinas Valley Health.[33]
  • 614 digital-ad clicks were recorded for Salinas Valley Health’s sports-medicine and orthopedics campaign during its initial three-month period.[33]
  • 24:1 was the reported return on investment for Salinas Valley Health’s sports-medicine and orthopedics campaign after three months of encounter data.[33]

Digital marketing in the orthopedics industry

  • 11.58% was the reported click-through rate for University Orthopaedic Associates’ Google Ads campaign.[30]
  • 209% was the increase in paid-search form submissions reported by University Orthopaedic Associates compared with 2023.[30]
  • 41% was the increase in Google Ads phone-call clicks reported by University Orthopaedic Associates compared with 2023.[30]
  • $10.85 was the reported average cost per conversion for University Orthopaedic Associates’ Google Ads campaign.[30]
  • 12.34% was the reported conversion rate for University Orthopaedic Associates’ Google Ads campaign.[30]

Branding in the orthopedics industry

  • 4.03 was the mean Healthgrades score for 210 orthopedic foot-and-ankle surgeons in the study cited by the 2021 social-media research.[27]
  • 90% of orthopedic foot-and-ankle surgeons in the cited research had at least one one-star rating.[27]
  • More than 40% of orthopedic patients referenced digital media when selecting a physician, according to a study of orthopedic foot-and-ankle care.[27]
  • 15.4 was the average number of reviews for the 210 orthopedic foot-and-ankle surgeons in the cited Healthgrades analysis.[27]

Social media in the orthopedics industry

  • 48.8% of 123 U.S. board-certified foot-and-ankle orthopedic surgeons used Facebook in the study sample.[27]
  • 52.9% of 123 U.S. board-certified foot-and-ankle orthopedic surgeons maintained a group website in the study sample.[27]
  • 23.6% of 123 U.S. board-certified foot-and-ankle orthopedic surgeons used YouTube in the study sample.[27]
  • 15.4% of 123 U.S. board-certified foot-and-ankle orthopedic surgeons used Twitter in the study sample.[27]
  • 47.9% of 123 U.S. board-certified foot-and-ankle orthopedic surgeons used LinkedIn in the study sample.[27]

Influencer Marketing in the healthcare services sector (sector benchmark)

  • 33% of U.S.-focused health and wellness influencers promoted a product, service or subscription in more than half of their posts in 2026.[34]
  • 50% of healthcare and pharmaceutical marketers reported dedicated, growing creator/influencer budgets in 2026, compared with 58% globally.[35]
  • 8.57 million influencer posts about the health industry generated a 1.07% average engagement rate globally in 2023.[36]
  • 92% of U.S.-focused health and wellness influencers included product or service promotions at least occasionally in 2026.[34]
  • 38% of posts from U.S.-focused health and wellness influencers promoted a product, service or subscription in 2026.[34]

10 Statistics

Operations & Execution

Operational metrics tie to throughput and infection outcomes; structured infection-prevention measures reduced surgical-site infection rates to 1.1% from 5.6%.

Process optimization in the orthopedics industry

  • 44% was the reduction in total-joint-arthroplasty operating-room turnover time after instrument-tray optimization in a U.S. orthopedic practice in 2023.[37]
  • $88,939 in annual sterile-processing costs were estimated to be saved after total-joint-arthroplasty tray optimization at one U.S. practice.[37]
  • 49 minutes per day of operating-room efficiency improvement was reported after positive-deviance sessions in a high-volume orthopedic arthroplasty setting.[2]
  • 19 minutes of average operating-room turnover time were eliminated after total-joint-arthroplasty instrument trays were reduced from seven to three in a U.S. study conducted in 2022–2023.[37]
  • $169,597 in annual operating-room costs were estimated to be saved after total-joint-arthroplasty tray optimization at one U.S. practice.[37]

Operational efficiency in the orthopedics industry

  • 70 unilateral hip and knee replacements were observed in a U.S. study comparing operating-room designs and orthopedic surgical efficiency.[37]
  • 71.4% of orthopedic operations experienced more than one hour of interprocedure waiting time in a university-hospital study.[38]
  • 13.9% of orthopedic operations with more than one hour between procedures had adverse events, versus 5.3% when the interval was shorter.[38]
  • 12,423 hip and knee arthroplasty cases represented 34.7% of 35,817 orthopedic cases in a seven-site U.S. academic health system during 2023–2025.[39]
  • 6,163 arthroscopy cases represented 17.2% of 35,817 orthopedic cases in a seven-site U.S. academic health system during 2023–2025.[39]

Quality management in the orthopedics industry

  • 1.1% was the overall surgical-site-infection rate after structured infection-prevention measures, down from 5.6% among orthopedic patients in the pre-intervention period.[2]
  • 2 Class I recalls occurred among 500 orthopedic-device recalls recorded in the United States during fiscal years 2020–2024.[40]
  • 57.0% hand-hygiene adherence before surgery was achieved after an infection-prevention bundle, compared with 9.7% before implementation in German trauma and orthopedic wards.[37]
  • 0.22% was the surgical-site-infection rate after high-efficiency particulate-air and ultraviolet air recirculation, compared with 0.45% before implementation at an orthopedic hospital.[37]
  • 2.4% was the post-intervention infection rate for hip arthroplasty, down from 9.2% in the 2019–2022 baseline period.[2]

Supply chain in the orthopedics industry

  • 37 days was the reported maximum delay for medical-supply containers during U.S. transportation congestion in 2021, affecting orthopedic-care supply availability.[41]
  • 40 basis points of Stryker’s 2023 gross-margin change were attributed to manufacturing and supply-chain costs.[42]
  • 17,000 employees worked for Zimmer Biomet worldwide as of December 31, 2025, supporting its global orthopedic manufacturing and supply network.[16]
  • 30.0 million dollars of Orthopediatrics’ 2024 revenue came from acquired Boston O&P sales, changing its pediatric orthopedic product-distribution mix.[43]
  • 2,000 Zimmer Biomet employees were dedicated to research and development worldwide as of December 31, 2025.[16]

Outsourcing / Offshoring in the healthcare services sector (sector benchmark)

  • 20% of U.S. medical-group leaders planned to outsource or automate some revenue-cycle-management activities in 2024, according to an MGMA poll with 262 responses.[23]
  • 29% of global healthcare providers used third-party providers for remote patient monitoring in 2024, based on a survey of 28 healthcare-provider executives.[44]
  • 43% of global healthcare providers used third-party providers for payroll services in 2024, based on a survey of 28 healthcare-provider executives.[44]
  • 18% of U.S. medical-group leaders planned to outsource or automate patient communications in contact centers in 2024, according to an MGMA poll with 262 responses.[23]
  • 46% of global healthcare providers used third-party providers for customer-experience services in 2024, based on a survey of 28 healthcare-provider executives.[44]

11 Statistics

Finance & Pricing

Pricing and margin signals are tracked alongside sales, including Stryker’s 11.5% gross-profit margin in 2024 after orthopedics-related effects.

Pricing strategy in the orthopedics industry

  • $204.7 million was Orthopediatrics’ 2024 revenue, with management attributing nearly all category growth to unit volume rather than price changes.[43]
  • 1.1% lower prices offset part of Stryker’s 2023 orthopedics growth, while unit volume increased 11.9% in constant currency.[42]
  • 9.2 billion dollars was Johnson & Johnson DePuy Synthes orthopedics sales in fiscal 2024, serving as the business’s global revenue base for pricing decisions.[45]
  • 20 basis points of sales pricing contributed to Stryker’s 2022 gross-margin change.[42]
  • China volume-based procurement headwinds affected Smith+Nephew’s 2024 orthopedics revenue and commercial performance.[46]

Cost reduction in the orthopedics industry

  • 31 surgical-site infections were estimated to have been prevented in 2023 through structured infection-prevention measures in orthopedic procedures.[37]
  • 308 hospital days were avoided in 2023 after infection-prevention measures were applied to orthopedic implant-associated procedures.[37]
  • $79.41 was the estimated sterile-processing cost for one total-joint-arthroplasty instrument tray in a U.S. cost-saving analysis.[37]
  • $209,188 to $376,898 was the modeled cost saving from orthopedic infection-prevention measures in 2024 U.S. dollars.[37]
  • $169,597 in annual operating-room savings resulted from optimizing total-joint-arthroplasty instrument trays at one U.S. orthopedic practice.[37]

Profitability in the orthopedics industry

  • $9.077 billion was Stryker’s orthopedics net sales in 2024, compared with $8.335 billion in 2023.[42]
  • 73% was Orthopediatrics’ gross margin in 2024, down from 75% in 2023.[43]
  • 63.9% was Stryker’s reported gross-profit margin in 2024 after orthopedics-related pricing, volume, manufacturing and supply-chain effects.[42]
  • 11.5% was Smith+Nephew’s 2024 orthopedics trading-profit margin, up 20 basis points from 2023.[47]
  • 71.0% was Orthofix’s 2024 non-GAAP adjusted gross margin, compared with 71.4% in 2023.[48]

Financial planning in the orthopedics industry

  • $50 billion or more was the global market opportunity identified by Johnson & Johnson for the future DePuy Synthes business.[45]
  • $124.2 million was Orthofix’s 2024 global-orthopedics revenue, up 7.9% on a constant-currency basis.[48]
  • $9.2 billion was Johnson & Johnson’s 2024 orthopedics sales, supporting its planned separation of DePuy Synthes as a standalone business.[45]
  • Approximately 7 million patients were served annually by DePuy Synthes, according to Johnson & Johnson’s 2025 separation announcement.[45]
  • $11.0 million was Orthopediatrics’ 2024 research-and-development expense, compared with $10.9 million in 2023.[43]

12 Statistics

Product & Service

Product lines are quantified by sales and by revision-risk estimates; e.g., Johnson & Johnson’s 2025 global knee-replacement sales were $3.77 billion.

Product development in the orthopedics industry

  • $76.4 million in 2025 sales came from Johnson & Johnson’s orthopedic enabling-technology products, up 7.4% from 2024, globally.[14]
  • $1.59 billion in 2025 sales came from Johnson & Johnson’s ATTUNE knee portfolio, whose growth was driven by new product launches, United States and global orthopedics.[49]
  • $2.79 billion in 2025 sales came from Johnson & Johnson’s orthopedic trauma products, up 2.9% from 2024, globally.[14]
  • 45 issued patents and approximately 120 pending patent applications supported Carlsmed’s AI-enabled orthopedic spine-planning platform at December 31, 2025.[17]
  • 12% growth in 2025 Surgical & Sports Medicine product revenue was reported by Orthogonal, reflecting product-development performance in orthopedic surgery, globally.[17]

Product lifecycle in the orthopedics industry

  • 5.3% was the estimated 10-year revision rate for the best-performing cemented fixed-bearing unicondylar knee brands in England and Wales.[50]
  • 3.2% was Kaiser Permanente’s overall revision rate among 135,165 primary total hip arthroplasties in its registry, United States.[10]
  • 1.6% was Kaiser Permanente’s overall revision rate for its total joint replacement registry in 2021, United States.[10]
  • 0.41% to 8.53% was the range of five-year revision estimates across ankle implant brands in England and Wales through 2024.[50]
  • 4.20% was the estimated 15-year revision rate for total knee replacements in England and Wales, based on procedures through 2023.[50]

After-sales in the orthopedics industry

  • 33% of knee revisions in England and Wales in 2023 were attributed to aseptic loosening or lysis.[50]
  • 615 revisions were recorded among 11,321 primary ankle replacements through the end of 2024 in England and Wales.[50]
  • 2% was the one-year re-revision rate when the first knee revision occurred 10 years after the primary operation, England and Wales.[50]
  • 9% was the one-year re-revision rate when the first knee revision occurred within one year of the primary operation, England and Wales.[50]
  • 400 single-stage and 105 two-stage ankle revision procedures were recorded through 2024 in England and Wales.[50]

Value proposition in the orthopedics industry

  • $3.77 billion was Johnson & Johnson’s 2025 global knee-replacement sales, up 2.6% from 2024.[14]
  • $1.67 billion was Johnson & Johnson’s 2025 global hip-replacement sales, up 2.1% from 2024.[14]
  • $1.52 billion was Johnson & Johnson’s fourth-quarter 2025 United States orthopaedics sales, up 4.2% year over year.[14]
  • $918.2 million was Johnson & Johnson’s fourth-quarter 2025 orthopaedics sales outside the United States, up 7.3% year over year.[14]
  • $574.6 million was CONMED’s 2025 orthopedic-surgery revenue, up 5.6% from 2024.[51]

13 Statistics

Sustainability & Ethics

Environmental and ethics reporting is stated with measured outputs, including Orthofix’s 1,735 tCO2e Scope 2 emissions in 2021.

Sustainability in the orthopedics industry

  • 3.142 million gallons of water were used by Orthofix worldwide in 2021.[52]
  • 58% of Zimmer Biomet’s in-scope network sites were Zero Waste to Landfill certified in 2025.[53]
  • 79 tons of hazardous waste were generated by Orthofix in 2021.[52]
  • 99% of Zimmer Biomet suppliers provided greenhouse-gas emissions data in 2024.[16]
  • 193 tons of non-hazardous waste were generated by Orthofix in 2021.[52]

ESG in the orthopedics industry

  • 32 languages were used for Zimmer Biomet’s Code of Business Conduct and Ethics in 2024.[16]
  • 100% of Stryker employees completed Code of Conduct training in 2024.[54]
  • 84% of Zimmer Biomet survey respondents rated its communication of ethical responsibilities favorably in 2024.[16]
  • 100% of Zimmer Biomet global team members and directors completed ethics training in 2024.[16]
  • 97% of Stryker people managers completed its culture-of-integrity course in 2024.[54]

Ethics in the orthopedics industry

  • $4.867 million was the mean indemnity payment in plaintiff-verdict hip-and-knee cases in the U.S. analysis.[55]
  • $38.5 million was paid by Aesculap Implant Systems to resolve U.S. allegations involving knee implants and physician remuneration.[56]
  • 544 settled orthopedic claims per financial year was the average in NHS England data from 1996/97 to 2023/24.[1]
  • 16 languages were available for Zimmer Biomet’s updated ethics training in 2024.[16]
  • 18.4% of hip-and-knee malpractice cases in the same analysis ended in plaintiff verdicts.[55]

CSR in the orthopedics industry

  • 21 postoperative cast shoes were collected in the same orthopedic donation pilot.[37]
  • 46% of Orthofix’s 2024 summer-internship participants met its diversity criteria.[17]
  • 4.5 million people had been reached through Johnson & Johnson community-health efforts in the United States since 2020.[57]
  • 213 durable orthopedic-equipment items were donated by one U.S. orthopedic clinic during its April 2024–April 2025 pilot.[37]
  • 37 pairs of crutches were collected in the one-year U.S. orthopedic donation pilot.[37]

Circular economy in the orthopedics industry

  • 57% of surveyed clinicians reused reprocessed implants and devices multiple times until visibly damaged.[1]
  • 87% of surveyed clinicians reused consumables such as gowns and drapes multiple times until visibly damaged.[1]
  • 21.8% of orthopedic-surgery waste per case was recyclable in a 2026 Pisa Hospital study.[58]
  • 51% of surveyed orthopedic clinicians used reprocessed implants or devices at least weekly in the 2026 REBOOT study.[1]
  • 67.8% of arthroplasty surgical waste was biological waste in the Pisa study.[58]

Carbon footprint in the orthopedics industry

  • 1,735 tCO2e were Orthofix’s 2021 location-based Scope 2 emissions worldwide.[52]
  • 190,139 metric tons of Scope 1 and 2 market-based CO2e were reported by Zimmer Biomet in 2017.[16]
  • 65% of Zimmer Biomet waste was recycled in 2024.[16]
  • 23% of Zimmer Biomet waste went to landfill in 2024.[16]
  • 871 tCO2e were Orthofix’s 2021 Scope 1 emissions worldwide.[52]

15 Statistics

Globalization & Expansion

Regional revenue concentration is quantified for key brands, including Medacta’s 48.0% of 2024 revenue in EMEA.

Globalization in the orthopedics industry

  • Medacta generated 48.0% of its 2024 revenue in EMEA, 30.4% in North America, 19.5% in Asia-Pacific and 2.1% in Latin America.[66]
  • $4.15 billion was Smith+Nephew’s orthopedic sales in 2025, up 5.9% from 2024.[14]
  • $64.95 billion was the worldwide orthopedic market in 2025, up 4.9% from 2024.[14]
  • $20.33 billion in orthopedic sales came from markets outside the United States in 2024, representing 32.8% of global sales.[15]
  • $3.61 billion was Medtronic’s orthopedic sales in 2025, up 5.3% from 2024.[14]

Distribution channels in the orthopedics industry

  • The rest of the world accounted for $2.08 billion of orthopedic sales in 2024, up 4.8% from 2023.[15]
  • Orthofix began selling directly to Canada in September 2018, Belgium and the Netherlands in January 2019, Italy in March 2020, and Germany, Switzerland and Austria in January 2021.[17]
  • Orthofix’s international growth was $4.3 million, or 5.0% on a constant-currency basis, in 2024, driven by European product launches and distributor orders.[67]
  • More than 75 countries were served by Össur through independent stocking distributors and sales agencies in 2025.[17]
  • Orthofix reported $27.3 million in first-quarter 2024 net sales, with U.S. growth of 22.9% driven partly by commercial execution in its sales channel.[68]

Key questions about the Orthopedics Industry

What was the global orthopedics market size in 2025?
The global orthopedics market reached $64.9 billion in 2025, supported by joint replacement, trauma and enabling technologies.
What growth rate is expected for orthopedics after 2025?
The forecast CAGR for 2026–2035 is 4.3%, and Global Market Insights projects orthopedic devices rising from $63.0 billion in 2026 to $92.2 billion in 2035.
Which companies lead the orthopedics industry?
Stryker and Johnson & Johnson are tied at the top of Gitnux's 2026 orthopedics ranking with an Overall score of 9.1 each.
How is technology changing orthopedics, based on current signals?
Robotics reached 6.7% use in U.S. hip, knee and spine surgeries in 2023. About 25% of operating rooms had access to an orthopaedic robot in 2025, and AI monitoring and image analysis are top-specified applications in a 2023 survey.
How concentrated is the orthopedics market structure?
Eight companies with more than $1 billion in annual orthopedic sales controlled about two-thirds of the worldwide market in 2025, generating more than $43.3 billion in combined orthopedic revenue.
What data and registry signals are used to evaluate orthopedic performance?
Kaiser Permanente’s implant-surveillance program included 170,520 hip-replacement procedures and 303,844 knee-replacement procedures through 2022, and its registry tracked 135,165 primary total hip arthroplasties through 2021.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Henrik Dahl. (2026, February 13). Orthopedics Industry Statistics. Gitnux. https://gitnux.org/orthopedics-industry-statistics
MLA
Henrik Dahl. "Orthopedics Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/orthopedics-industry-statistics.
Chicago
Henrik Dahl. 2026. "Orthopedics Industry Statistics." Gitnux. https://gitnux.org/orthopedics-industry-statistics.

Sources & references

81 sources cited across this report

  1. link.springer.com
  2. pmc.ncbi.nlm.nih.gov
  3. gabelli.com
  4. business.adobe.com
  5. deloitte.com
  6. healthit.gov
  7. kpmg.com
  8. go.rackspace.com
  9. cetic.br
  10. deviceassessment.kaiserpermanente.org
  11. accessdata.fda.gov
  12. carta.healthcare
  13. intersystems.com
  14. orthoworld.com
  15. bonezonepub.com
  16. investor.zimmerbiomet.com
  17. sec.gov
  18. admin.alkemlabs.com
  19. tendo.com
  20. maxxortho.com
  21. onetonline.org
  22. journals.lww.com
  23. mgma.com
  24. wfhresearch.com
  25. england.nhs.uk
  26. pressganey.com
  27. journals.sagepub.com
  28. surgicoll.scholasticahq.com
  29. thebryanagency.net
  30. katavamarketing.com
  31. ooa.memberclicks.net
  32. liine.com
  33. salinasvalleyhealth.com
  34. pewresearch.org
  35. brand-news.it
  36. media.sproutsocial.com
  37. pubmed.ncbi.nlm.nih.gov
  38. sciencedirect.com
  39. andrewtduncan.com
  40. files.gao.gov
  41. axios.com
  42. s22.q4cdn.com
  43. ir.orthopediatrics.com
  44. tcs.com
  45. investor.jnj.com
  46. lobbyregister.bundestag.de
  47. cdn.yahoofinance.com
  48. s21.q4cdn.com
  49. jnj.com
  50. ncbi.nlm.nih.gov
  51. conmed.gcs-web.com
  52. orthofix.com
  53. hub.zimmerbiomet.com
  54. stryker.com
  55. arthroplastyjournal.org
  56. justice.gov
  57. time.com
  58. arpi.unipi.it
  59. ache.org
  60. proofpoint.com
  61. ponemonsullivanreport.com
  62. kff.org
  63. hfmmagazine.com
  64. sophos.com
  65. quidelortho.com
  66. financialfilings.com
  67. ebs.publicnow.com
  68. d18rn0p25nwr6d.cloudfront.net
  69. gminsights.com
  70. bls.gov
  71. grandviewresearch.com
  72. aaos.org
  73. new.aaos.org
  74. fda.gov
  75. newsroom.arthrex.com
  76. medacta.com
  77. ossur.com
  78. ir.enovis.com
  79. ir.orthofix.com
  80. 20984690.fs1.hubspotusercontent-na1.net
  81. cms.gov